-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
CASI Pharmaceuticals, Inc (DE) quarterly/annual Operating Income (Loss) history and growth rate from Q3 2018 to Q4 2022.
- CASI Pharmaceuticals, Inc (DE) Operating Income (Loss) for the quarter ending December 31, 2022 was -$12.6M, a 14.4% decline year-over-year.
- CASI Pharmaceuticals, Inc (DE) Operating Income (Loss) for the twelve months ending December 31, 2022 was -$34M, a 18% increase year-over-year.
- CASI Pharmaceuticals, Inc (DE) annual Operating Income (Loss) for 2022 was -$34M, a 18% increase from 2021.
- CASI Pharmaceuticals, Inc (DE) annual Operating Income (Loss) for 2021 was -$41.5M, a 21.3% increase from 2020.
- CASI Pharmaceuticals, Inc (DE) annual Operating Income (Loss) for 2020 was -$52.8M, a 12.4% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)